Toggle light / dark theme

Circa 2021 Synthetic silicon dna storage.


In research, the demand for DNA strands often outpaces supply. To help supply keep up, researchers may set aside traditional molecular cloning techniques and embrace polymerase chain reaction select PCR)-based techniques. Alternatively, researchers may perform gene synthesis, or the de novo chemical synthesis of DNA. Besides accelerating the creation of genetic sequences, gene synthesis avoids the need for template strands and simplifies procedures such as codon optimization and the fabrication of mutant sequences.

Although gene synthesis can be performed in house, many laboratories prefer to focus on their core competencies and outsource their gene synthesis projects to service providers, especially if sequences of over 1,000 base pairs are desired. Outsourcing also allows laboratories to take advantage of service providers’ economies of scale and quick turnaround times. Finally, service providers offer ease of use. Clients can go online, upload the desired sequences, choose the vector, get the price, and place the order. The entire process takes only a few minutes, and the genes can be delivered a few days later.

Researchers needing a few genes have a choice of several providers. But what if researchers need 10,000 genes? “We’re probably the only game in town,” suggests Emily Leproust, PhD, co-founder and CEO of Twist Bioscience.

Josh SeehermanI don’t think he’s wrong.

Walter Lynsdale” agreeing with a Twitter user who said the “Woke mind virus is the biggest threat to civilization,”

… not nuclear war, or fossil fuel dependence? 😕

View 2 more comments.

Traditionally, research showed tumor tissue to be free of microbes. In recent years, however, technology has advanced, allowing scientists to detect tiny numbers of bacteria that have taken up residence inside tumor tissue. For example, Shang Cai and his team detected 135,000 microorganisms in a gram of mouse breast tumor tissue, almost ten times more than in healthy tissue. (By comparison, a gram of feces has roughly 300 billion microbes.) Furthermore, nearly all the bacteria were living inside the mouse cells.

The biological significance of the intratumor microbiota remains largely unknown. However, scientists have found that the gut microbiota contributes to tumor progression. Cai wanted to know if these tumor-infesting intracellular bacteria are also involved in cancer progression.

CARMAT, the developer of the world’s most advanced completely artificial heart has successfully raised €40.5 million in funding. The raise is set to finance the production of their Aeson artificial heart, which the company hopes will provide an alternative treatment option for people with heart failure – a condition affecting around 6.2 million adults in the US alone [1].

Longevity. Technology: Beating around 100,000 times per day, your heart works around the clock to keep your circulatory system ticking. The steady sound of your heartbeat is a comforting constant throughout your life. Forming the centre of the circulatory system, the heart continuously pumps blood around the body to deliver oxygen and nutrients to cells. Due to this constant work, our hearts can unfortunately wear out as we age, with cardiovascular diseases continuing to be the leading causes of death globally [2].

End-stage heart failure is a serious condition that occurs when the heart can no longer transport blood throughout the body effectively. It most often affects the left chamber of the heart, which pumps oxygen-rich blood around the body, leading to biventricular heart failure. Vital organs like the brain, liver and kidney fail to get enough oxygen and nutrients to function properly. With few treatment options, end-stage heart failure sometimes requires serious intervention like heart transplantation – considered the gold standard therapy. However, due to the global shortage in organ donors, this is not always possible and there is a gap for a therapeutic alternative that could have huge implications for longevity globally.

NEW YORK – A collaboration between researchers at Columbia and the Icahn School of Medicine is embarking on a project that will generate comprehensive atlases of entire human brains and all their 180+ billion cells. This kind of data can help uncover how the structure and organization of the brain give rise to behavior, emotion and cognition, in sickness and in health.

Credit: Hillman Lab/Columbia’s Zuckerman Institute.

Obesity and its consequences on overall health have become a serious global problem. However, very few substances or drugs can fight obesity. In a recent study, Japanese researchers investigated the anti-obesity effects of tocotrienols, a subtype of vitamin E. Experiments showed that tocotrienols significantly reduce the weight gained by mice on a high-fat diet, while also lowering “bad” cholesterol levels. The results pave the way to efficient treatments for obesity.

Over the past few decades, obesity has become increasingly common throughout the entire world. Since obesity often causes other diseases, including diabetes and various cardiovascular disorders, it represents an alarming social problem in both developed and developing countries. Although most of us know that a balanced diet and plenty of exercise are the best ways to prevent obesity, having drugs to effectively treat it would still come in handy if necessary.

Unfortunately, there are very few known substances or drugs that can help prevent or treat obesity and its dreaded secondary diseases. One problem is that some of the mechanisms of obesity-induced diseases are unclear. For example, there is some evidence showing that obesity increases oxidative stress (oxidation) in the body. In turn, some scientists suspect that increased oxidation is the reason why obesity paves the way for neurodegenerative disorders like Alzheimer’s disease. Taking this into account, it might be helpful if potential drugs for treating obesity also had strong antioxidant functions.